Edward C. Chao

1.2k total citations · 1 hit paper
10 papers, 955 citations indexed

About

Edward C. Chao is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Edward C. Chao has authored 10 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Edward C. Chao's work include Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetes Management and Research (2 papers). Edward C. Chao is often cited by papers focused on Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetes Management and Research (2 papers). Edward C. Chao collaborates with scholars based in United States. Edward C. Chao's co-authors include Robert R. Henry, Joseph Wang, Christopher M. Brown, Ernesto De la Paz, Abbas Barfidokht, Anna Chang, Sunita Baxi, Vanita R. Aroda, P. Burke and Daniel T. O’Connor and has published in prestigious journals such as Analytical Chemistry, Nature Reviews Drug Discovery and Diabetes.

In The Last Decade

Edward C. Chao

10 papers receiving 933 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 inhibition — a novel strategy for diabetes treatment

2010 662 citations Edward C. Chao, Robert R. Henry Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Edward C. Chao

Since Specialization

Citations

This map shows the geographic impact of Edward C. Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward C. Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward C. Chao more than expected).

Fields of papers citing papers by Edward C. Chao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward C. Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward C. Chao. The network helps show where Edward C. Chao may publish in the future.

Co-authorship network of co-authors of Edward C. Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Edward C. Chao. A scholar is included among the top collaborators of Edward C. Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward C. Chao. Edward C. Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Collaboratively Designing an App for a More Personalized, Community-Endorsed Continuous Glucose Monitoring Onboarding Experience: An Early Study 2023 ·Journal of Diabetes Science and Technology ·Edward C. Chao, (unknown), (unknown), (unknown)	1
2	Extended Noninvasive Glucose Monitoring in the Interstitial Fluid Using an Epidermal Biosensing Patch 2021 ·Analytical Chemistry ·Ernesto De la Paz, Abbas Barfidokht, (unknown), Christopher M. Brown, Edward C. Chao, Joseph Wang	87
3	72-LB: Novel Epidermal Adhesive Sensors to Enhance Continuous Glucose Measurement in Patients with Diabetes: The EASE Study 2020 ·Diabetes ·Edward C. Chao, (unknown), Abbas Barfidokht, Joseph Wang	2
4	SGLT-2 Inhibitors: A New Mechanism for Glycemic Control 2014 ·Clinical Diabetes ·Edward C. Chao	159
5	Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes 2012 ·PubMed ·Edward C. Chao	9
6	Dapagliflozin—redefining treatment of T2DM? 2011 ·Nature Reviews Endocrinology ·Edward C. Chao	1
7	A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors. 2011 ·Discovery Medicine ·Edward C. Chao	19
8	SGLT2 inhibition — a novel strategy for diabetes treatment breakdown → 2010 ·Nature Reviews Drug Discovery ·Edward C. Chao, Robert R. Henry	662
9	Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes 2009 ·Diabetes Obesity and Metabolism ·Sunder Mudaliar, Anna Chang, Vanita R. Aroda, Edward C. Chao, P. Burke, Sunita Baxi, (unknown), Daniel T. O’Connor, Robert R. Henry	14
10	WEIGHT GAIN AND FAT DISTRIBUTION WITH PIOGLITAZONE IN PATIENTS WITH TYPE 2 DIABETES ON INSULIN THERAPY. 2007 ·Journal of Investigative Medicine ·(unknown), Sunder Mudaliar, Vanita R. Aroda, (unknown), Edward C. Chao, Amelia Chang, (unknown), P. Burke, (unknown), Robert R. Henry	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact